Menu
D8 Holdings Corp. is a recently formed company whose business purpose is merger and acquisitions in the consumer sector. The company's objective is to identify a target business that is under-valued relative to its potential and ready for transformative improvement.
We recently compiled a list of the 10 Best Medical AI Companies. In this article, we are going to take a look at where Vicarious Surgical Inc. (NYSE:RBOT) stands against the other medical AI companies. The Need for AI in Healthcare Generally, when you hear the term “artificial intelligence,” your mind jumps straight to semiconductor and […]
https://www.investing.com/news/company-news/vicarious-surgical-ceo-sells-shares-worth-over-4400-93CH-3581808
Vicarious Surgical to present at Morgan Stanley Healthcare Conference, showcasing innovative robotic surgery technology. Learn about the future of surgical procedures on Sept 6, 2024, at 11:30 AM ET.
BOULDER, CO / ACCESSWIRE / August 21, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous stray ener…
Encision partners with Vicarious Surgical to enhance robotic surgery safety. Learn how this collaboration aims to bring cutting-edge Active Electrode Monitoring technology to surgical robotics, improving patient outcomes.
BOULDER, CO / ACCESSWIRE / August 21, 2024 / Encision Inc. (OTC PINK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM) Technology that prevents dangerous stray energy burns in minimally invasive surgery, today … Jetzt den vollständigen Artikel lesen
Vicarious Surgical (NYSE: RBOT ) just reported results for the second quarter of 2024. Vicarious Surgical reported earnings per share of -$2.86. This was below the analyst estimate for EPS of -$2.77. The company did not report any revenue for the quarter. InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com. More From InvestorPlace Legendary Investor Predicts: “Forget AI… THIS Technology Is the Future” The post RBOT Stock Earnings: Vicarious Surgical Misses EPS for Q2 2024 appeared first on InvestorPlace .
No summary available.
No summary available.
Vicarious Surgical reports Q2 2024 results: On track for V1.0 milestone, partners with LSU Health. Despite losses, expenses down 17%. Learn about their progress and financial position.